Abstract

AMP deaminase isoforms purified from endogenous sources display smaller than predicted subunit molecular masses, whereas baculoviral expression of human AMPD1 (isoform M) and AMPD3 (isoform E) cDNAs produces full-sized recombinant enzymes. However, nearly 100 N-terminal amino acid residues are cleaved from each recombinant polypeptide during storage at 4 degreesC. Expression of N-truncated cDNAs (DeltaL96AMPD1 and DeltaM90AMPD3) produces stable recombinant enzymes exhibiting subunit molecular masses and kinetic properties that are similar to those reported for purified isoforms M and E. Conversely, wild type recombinant isoforms display significantly higher Km(app) values in the absence of ATP. Gel filtration analysis demonstrates native tetrameric structures for all recombinant proteins, except the wild type AMPD1 enzyme, which forms aggregates of tetramers that disperse upon cleavage of N-terminal residues at 4 degreesC. These data: 1) confirm that available literature on AMP deaminase is likely derived from N-truncated enzymes and 2) are inconsistent with a new model proposing native trimeric structure of an N-truncated rabbit skeletal muscle AMP deaminase (Ranieri-Raggi, M., Montali, U., Ronca, F., Sabbatini, A., Brown, P. E., Moir, A. J. G., and Raggi, A. (1997) Biochem. J. 326, 641-648). N-terminal residues also influence actomyosin-binding properties of the enzyme, which are enhanced and suppressed by AMPD1 and AMPD3 sequences, respectively. Finally, co-expression of AMPD1 and AMPD3 recombinant polypeptides produces tetrameric enzymes with either isoform-specific or mixed subunits, and also reveals that tetramer assembly is driven by relative polypeptide abundance with no apparent preference for like subunits.

Highlights

  • AMP deaminase (AMPD1; EC 3.5.4.6) is a diverse tetrameric enzyme that catalyzes a branchpoint reaction in the adenylate catabolic pathway

  • Baculoviral Expression and Phosphocellulose Purification of Wild Type Human AMPD Recombinant Enzymes—AMPD activities of 82–204 milliunits/mg protein have been reported in crude extracts prepared from bacterial cells following expression of wild type mammalian AMPD1 and AMPD3 cDNAs from prokaryotic vectors (20 –23)

  • SDS-PAGE analysis of peak active fractions (Fig. 2, lanes 1 and 4) reveals subunit molecular masses that are similar to those predicted from cDNA sequences (87 kDa, AMPD1; 89 kDa, AMPD3)

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Grace’s insect cell culture medium and fetal bovine serum were obtained from Life Technologies, Inc. 1) A ⌬L96AMPD1 cDNA was constructed using a 28-mer oligonucleotide designed to include created sequence (lowercase) containing an NcoI restriction endonuclease site (underlined) fused to sense strand sequence (uppercase) immediately upstream of the L96 codon (italicized), 5Ј-ctggatccatggAACTGTCCCACATTGA-3Ј. 2) A ⌬M90AMPD3 cDNA was constructed using a 27-mer oligonucleotide designed from sense strand sequence to create a BamHI restriction endonuclease site (underlined; mutations boldface) upstream of the M90 codon, 5Ј-GTTTCAAGAGGATCCGGTCCCAGTCCC-3Ј This primer was used in a PCR reaction with a downstream 17-mer antisense oligonucleotide, 5Ј-AGGACTGCGGCCGTAGA-3Ј. Gel Filtration Chromatography—Phosphocellulose-purified AMPD recombinant enzymes were dialyzed overnight at 4 °C against 1000 volumes of 50 mM imidazole, pH 6.5 (AMPD1), pH 6.7 (AMPD1/ AMPD3), or pH 7.0 (AMPD3), containing 500 mM potassium chloride and 1 mM dithiothreitol, passed over a 1 ϫ 90-cm glass column packed with Sephacryl S-300HR resin (Amersham Pharmacia Biotech; exclusion volume Ͼ2000 kDa) equilibrated in dialysis buffer.

RESULTS
Specific activity
DISCUSSION
Skeletal muscle Recombinant
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call